Health experts from around the world met November 29 to discuss ways to tackle an emerging crisis.
A recent summit explored how technological advances could impact patient care.
We teamed up with Medikidz and the COPD Foundation to develop a creative way to explain COPD to children.
The event, called “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016, on the Novartis Campus in Basel, Switzerland and will also be webcast.
The World Health Organization (WHO) passed a resolution on psoriasis that creates an urgent call to action for the international community.
Learn how we are shifting from making the patient fit the treatment to making the treatment fit the patient.
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
Dr. George Vratsanos, rheumatologist and Executive Global Program Head at Novartis Pharmaceuticals, shares his team’s top five principles that are at the heart of our clinical trial program.
We asked patients for their feedback on an upcoming clinical trial in Australia. Here’s what they said.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.